Among the training cohort, significant differences were identified between CR and non‐CR patients in HE4 levels, maximum tumor diameter, total bilirubin, PCOS, insulin resistance, Ki‐67 levels, and myometrial invasion. This evidence concerns the gene MKI67 and neoplasm.